Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo. Try Elite Free for 7 Days

T

TRAX

First Tracks Biotherapeutics Inc

43.11

Aug 21 • 3:59 PM ET 0.00 (0.00%)

Healthcare Biotechnology USA NASD

Peers: VBIO LABT COAG ABVC AARD ABEO ABOS ACET SRXH AAPG

| Held by: VTI XBI IWM VXF IWO VTWO SCHA IWC VHT IWN

Index	-
Market Cap	-
Enterprise Value	-
Income	-
Sales	-
Book/sh	4.77
Cash/sh	-
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	-
IPO	Apr 06, 2026

P/E	-
Forward P/E	-
PEG	-
P/S	-
P/B	9.04
P/C	-
P/FCF	-
EV/EBITDA	-
EV/Sales	-
Quick Ratio	14.28
Current Ratio	14.28
Debt/Eq	0.03
LT Debt/Eq	0.01
Option/Short	Yes / Yes

EPS (ttm)	-
EPS next Y	-3.66
EPS next Q	-0.88
EPS this Y	27.70%
EPS next Y	9.76%
EPS next 5Y	11.20%
EPS past 3/5Y	- -
Sales past 3/5Y	- -
EPS Y/Y TTM	-
Sales Y/Y TTM	-
EPS Q/Q	-
Sales Q/Q	-
Earnings	Aug 12 AMC
EPS/Sales Surpr.	-18.37% -

Insider Own	-
Insider Trans	-
Inst Own	-
Inst Trans	254.46%
ROA	-
ROE	-
ROIC	-
Gross Margin	-
Oper. Margin	-
Profit Margin	-
SMA20	-3.58%
SMA50	30.42%
SMA200	63.70%
Trades

Shs Outstand	35.39M
Shs Float	-
Short Float	-
Short Ratio	5.26
Short Interest	3.96M
52W High	49.91 -13.63%
52W Low	14.72 192.87%
Volatility	7.46% 8.44%
ATR (14)	3.47
RSI (14)	55.37
Beta	-
Rel Volume	0.00
Avg Volume	752.17K
Volume	0

Perf Week	-2.11%
Perf Month	14.53%
Perf Quarter	157.22%
Perf Half Y	-
Perf YTD	115.55%
Perf Year	-
Perf 3Y	-
Perf 5Y	-
Perf 10Y	-
Recom	1.11
Target Price	69.44
Prev Close	43.11
Price	43.11
Change %	0.00%

Date	Action	Analyst	Rating Change	Price Target Change
Aug-18-26	Initiated	Wolfe Research	Outperform	$83
Jun-08-26	Initiated	Wells Fargo	Overweight	$30
May-04-26	Initiated	Piper Sandler	Overweight	$54
Apr-28-26	Initiated	H.C. Wainwright	Buy	$30
Apr-24-26	Initiated	Wedbush	Outperform	$30
Apr-24-26	Initiated	Leerink Partners	Outperform	$46
Apr-23-26	Initiated	JP Morgan	Overweight	$31
Apr-22-26	Initiated	Barclays	Overweight	$40
Apr-21-26	Initiated	UBS	Buy	$45

Aug-12-26 04:15PM	First Tracks Biotherapeutics Announces Second Quarter 2026 Financial Results and Provides Business Update (GlobeNewswire)
Jul-10-26 12:14PM	TRAX Stock Hits All-Time High What's Driving The Super Rally? (Stocktwits) +11.85%
Apr-20-26 09:15AM	First Tracks Biotherapeutics Debuts on Nasdaq to Advance Therapies for Autoimmune Diseases (GlobeNewswire) -17.37%

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Jain Rita	Director	Jun 15 '26	Option Exercise	0.00	7,330	0	19,194	Jun 17 04:05 PM
Schmid John P.	Director	Jun 15 '26	Option Exercise	0.00	6,030	0	37,652	Jun 17 04:05 PM
Orwin John A	Director	Jun 15 '26	Option Exercise	0.00	6,030	0	16,695	Jun 17 04:05 PM
Ware J. Anthony	Director	Jun 15 '26	Option Exercise	0.00	6,030	0	15,660	Jun 17 04:05 PM
Marquet Magda	Director	Jun 15 '26	Option Exercise	0.00	6,030	0	15,960	Jun 17 04:05 PM
FENTON DENNIS M	Director	Jun 15 '26	Option Exercise	0.00	6,030	0	10,995	Jun 17 04:05 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 1 minute for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)